Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

Background. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous antiangiogenic hormone with anticancer activity. In a phase I study of Ang-(1-7), two of three patients with metastatic sarcoma experienced disease stabilization. This phase II study examined clinical and biomarker outcomes for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Savage, Paul D., Lovato, James, Brosnihan, K. Bridget, Miller, Antonius A., Petty, W. Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118533/
https://www.ncbi.nlm.nih.gov/pubmed/27895527
http://dx.doi.org/10.1155/2016/4592768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118533/
https://www.ncbi.nlm.nih.gov/pubmed/27895527
http://dx.doi.org/10.1155/2016/4592768

Ejemplares similares